{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:14:33Z","timestamp":1791101673367,"version":"4.1.0"},"reference-count":46,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Drug-associated dysfunction of mitochondria is believed to play a role in the etiology of the various adverse symptoms that occur in human immunodeficiency virus (HIV)-infected patients treated with the nucleoside reverse transcriptase inhibitors (NRTIs). Tenofovir, a nucleotide analog recently approved for use in the treatment of HIV infection, was evaluated in vitro for its potential to cause mitochondrial toxicity and was compared to currently used NRTIs. Treatment with tenofovir (3 to 300 \u03bcM) for up to 3 weeks produced no significant changes in mitochondrial DNA (mtDNA) levels in human hepatoblastoma (HepG2) cells, skeletal muscle cells (SkMCs), or renal proximal tubule epithelial cells. The potencies of inhibition of mtDNA synthesis by the NRTIs tested were zalcitabine (ddC) &gt; didanosine (ddI) &gt; stavudine &gt; zidovudine (ZDV) &gt; lamivudine = abacavir = tenofovir, with comparable relative effects in the three cell types. Unlike ddC and ddI, tenofovir did not affect cellular expression of COX II and COX IV, two components of the mitochondrial cytochrome\n            <jats:italic>c<\/jats:italic>\n            oxidase complex. Lactate production was elevated by less than 20% in HepG2 cells or SkMCs following treatment with 300 \u03bcM tenofovir. In contrast, lactate synthesis increased by &gt;200% in the presence of 300 \u03bcM ZDV. Thus, treatment of various human cell types with tenofovir at concentrations that greatly exceed those required for it both to have in vitro anti-HIV type 1 activity in peripheral blood mononuclear cells (50% effective concentration, 0.2 \u03bcM) and to achieve therapeutically relevant levels in plasma (maximum concentrations in plasma, 0.8 to 1.3 \u03bcM) is not associated with mitochondrial toxicity.\n          <\/jats:p>","DOI":"10.1128\/aac.46.3.716-723.2002","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:56:57Z","timestamp":1027763817000},"page":"716-723","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":365,"title":["Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors"],"prefix":"10.1128","volume":"46","author":[{"given":"Gabriel","family":"Birkus","sequence":"first","affiliation":[{"name":"Gilead Sciences, Foster City, California 94404"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J. M.","family":"Hitchcock","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, California 94404"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Cihlar","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, California 94404"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"724","volume":"70","year":"1994","unstructured":"Anderson, T. D., A. Davidovich, D. Feldman, T. J. Sprinkle, J. Arezzo, C. Brosnan, R. O. Calderon, L. H. Fossom, J. T. DeVries, and G. H. DeVries. 1994. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity. Lab. Investig.70:724-739.","journal-title":"Lab. Investig."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91294-5"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.10.2733-2739.2001"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(97)05376-8"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2796.1994.tb01088.x","volume":"235","year":"1994","unstructured":"Bissuel, F., F. Bruneel, F. Habersetzer, D. Chassard, L. Cotte, M. Chevallier, J. Bernuau, J. C. Lucet, and C. Trepo. 1994. Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J. Intern. Med.235:367-371.","journal-title":"J. Intern. Med."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199814000-00004"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-5793(99)00783-8","volume":"454","year":"1999","unstructured":"Chandel, N. S., and P. T. Schumacker. 1999. Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms. FEBS Lett.454:173-176.","journal-title":"FEBS Lett."},{"key":"e_1_3_2_9_2","first-page":"625","volume":"39","year":"1991","unstructured":"Chen, C. H., M. Vazquez-Padua, and Y. C. Cheng. 1991. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol. Pharmacol.39:625-628.","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632029500600403"},{"key":"e_1_3_2_11_2","unstructured":"Antivir. Res."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632029700800302"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-100002341"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1139\/o91-089","volume":"69","year":"1991","unstructured":"Cooper, C. E., P. Nicholls, and J. A. Freedman. 1991. Cytochrome c oxidase: structure, function, and membrane topology of the polypeptide subunits. Biochem. Cell. Biol.69:586-607.","journal-title":"Biochem. Cell. Biol."},{"key":"e_1_3_2_15_2","first-page":"1228","volume":"280","year":"1997","unstructured":"Cui, L., L. Locatelli, M. Y. Xie, and J. P. Sommadossi. 1997. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells. J. Pharmacol. Exp. Ther.280:1228-1234.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(96)00562-X"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117698"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004193221602"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290353"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1418"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/mus.880121012","volume":"12","year":"1989","unstructured":"Dubinsky, R. M., R. Yarchoan, M. Dalakas, and S. Broder. 1989. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2\",3\"-dideoxycytidine (ddC). Muscle Nerve12:856-860.","journal-title":"Muscle Nerve"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003495-200060020-00015","volume":"60","year":"2000","unstructured":"Hervey, P. S., and C. M. Perry. 2000. Abacavir: a review of its clinical potential in patients with HIV infection. Drugs60:447-479.","journal-title":"Drugs"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)90004-3"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0595-417"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115722"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1073\/pnas.93.8.3592","volume":"93","year":"1996","unstructured":"Lewis, W., E. S. Levine, B. Griniuviene, K. O. Tankersley, J. M. Colacino, J. P. Sommadossi, K. A. Watanabe, and F. W. Perrino. 1996. Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. Proc. Natl. Acad. Sci. USA93:3592-3597.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.1021\/bi00252a030","volume":"33","year":"1994","unstructured":"Lewis, W., R. R. Meyer, J. F. Simpson, J. M. Colacino, and F. W. Perrino. 1994. Mammalian DNA polymerases alpha, beta, gamma, delta, and epsilon incorporate fialuridine (FIAU) monophosphate into DNA and are inhibited competitively by FIAU triphosphate. Biochemistry33:14620-14624.","journal-title":"Biochemistry"},{"key":"e_1_3_2_28_2","first-page":"228","volume":"65","year":"1991","unstructured":"Lewis, W., T. Papoian, B. Gonzalez, H. Louie, D. P. Kelly, R. M. Payne, and W. W. Grody. 1991. Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab. Investig.65:228-236.","journal-title":"Lab. Investig."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.12.2743"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0925-4439(97)00061-6","volume":"1362","year":"1997","unstructured":"Marusich, M. F., B. H. Robinson, J. W. Taanman, S. J. Kim, R. Schillace, J. L. Smith, and R. A. Capaldi. 1997. Expression of mtDNA and nDNA encoded respiratory chain proteins in chemically and genetically derived Rho0 human fibroblasts: a comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome. Biochim. Biophys. Acta1362:145-159.","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","volume":"333","year":"1995","unstructured":"McKenzie, R., M. W. Fried, R. Sallie, H. Conjeevaram, A. M. Di Bisceglie, Y. Park, B. Savarese, D. Kleiner, M. Tsokos, C. Luciano, et al. 1995. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N. Engl. J. Med.333:1099-1105.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.8.1824"},{"key":"e_1_3_2_33_2","first-page":"192","volume":"133","year":"2000","unstructured":"Miller, K. D., M. Cameron, L. V. Wood, M. C. Dalakas, and J. A. Kovacs. 2000. Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann. Intern. Med.133:192-196.","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02633970","volume":"31","year":"1995","unstructured":"Morshed, K. M., and K. E. McMartin. 1995. Transient alterations in cellular permeability in cultured human proximal tubule cells: implications for transport studies. In Vitro Cell. Dev. Biol. Anim.31:107-114.","journal-title":"Dev. Biol. Anim."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80064-8"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.1998.2540389.x"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.496-503.2000"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0166-3542(97)01033-4","volume":"34","year":"1997","unstructured":"Parker, W. B., S. C. Shaddix, R. Vince, and L. L. Bennett. 1997. Lack of mitochondrial toxicity in CEM cells treated with carbovir. Antivir. Res.34:131-136.","journal-title":"Antivir. Res."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2165\/00003495-199753040-00008","volume":"53","year":"1997","unstructured":"Perry, C. M., and D. Faulds. 1997. Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. Drugs53:657-680.","journal-title":"Drugs"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.65.070196.003023"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1086\/302590","volume":"65","year":"1999","unstructured":"Rahman, S., J. W. Taanman, J. M. Cooper, I. Nelson, I. Hargreaves, B. Meunier, M. G. Hanna, J. J. Garcia, R. A. Capaldi, B. D. Lake, J. V. Leonard, and A. H. Schapira. 1999. A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy. Am. J. Hum. Genet.65:1030-1039.","journal-title":"Am. J. Hum. Genet."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.3.612"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3440915"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199708000-00034"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.11.1908"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.6.1555"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s004010051196","volume":"100","year":"2000","unstructured":"Yerroum, M., C. Pham-Dang, F. J. Authier, I. Monnet, R. Gherardi, and P. Chariot. 2000. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits. Acta Neuropathol. (Berlin)100:82-86.","journal-title":"Acta Neuropathol. (Berlin)"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.3.716-723.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.3.716-723.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:41:22Z","timestamp":1645465282000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.46.3.716-723.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1128\/AAC.46.3.716-723.2002"],"URL":"https:\/\/doi.org\/10.1128\/aac.46.3.716-723.2002","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"2001-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-12-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}